SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-77064"
 

Sökning: id:"swepub:oai:DiVA.org:uu-77064" > Long-term persisten...

Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori

Sjölund, Maria (författare)
Uppsala universitet,Institutionen för medicinska vetenskaper,Klinisk bakteriologi
Wreiber, Karin (författare)
Andersson, Dan I (författare)
Uppsala universitet,Institutionen för folkhälso- och vårdvetenskap
visa fler...
Blaser, Martin J (författare)
Engstrand, Lars (författare)
Karolinska Institutet,Uppsala universitet,Institutionen för medicinska vetenskaper
visa färre...
 (creator_code:org_t)
American College of Physicians, 2003
2003
Engelska.
Ingår i: Annals of Internal Medicine. - : American College of Physicians. - 0003-4819 .- 1539-3704. ; 139:6, s. 483-7
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
Abstract Ämnesord
Stäng  
  • BACKGROUND: Antibiotic treatment selects for resistance not only in the pathogen to which it is directed but also in the indigenous microflora. OBJECTIVE: To determine whether a widely used regimen (clarithromycin, metronidazole, and omeprazole) for Helicobacter pylori eradication affects resistance development in enterococci. DESIGN: Cohort study. SETTING: Endoscopy units at 3 community hospitals in Sweden. PATIENTS: 5 consecutive dyspeptic patients who were colonized with H. pylori, had endoscopy-confirmed duodenal ulcer, and received antibiotic treatment, and 5 consecutive controls with dyspepsia but no ulcer who did not receive treatment. MEASUREMENTS: Fecal samples were obtained from patients and controls before, immediately after, 1 year after, and 3 years after treatment. From each patient and sample, enterococci were isolated and analyzed for DNA fingerprint, clarithromycin susceptibility, and presence of the erm(B) gene. RESULTS: In treated patients, all enterococci isolated immediately after treatment showed high-level clarithromycin resistance due to erm(B). In 3 patients, resistant enterococci persisted for 1 to 3 years after treatment. No resistance developed among controls. CONCLUSION: A common H. pylori treatment selects for highly resistant enterococci that can persist for at least 3 years without further selection.

Nyckelord

Aged; Aged
80 and over
Anti-Bacterial Agents/*therapeutic use
Anti-Ulcer Agents/therapeutic use
Clarithromycin/therapeutic use
Drug Resistance; Bacterial
Drug Therapy; Combination
Duodenal Ulcer/drug therapy/microbiology
Enterococcus/*drug effects
Female
Helicobacter Infections/*drug therapy/microbiology
Helicobacter pylori
Humans
Male
Metronidazole/therapeutic use
Middle Aged
Omeprazole/therapeutic use
Prospective Studies
Research Support; Non-U.S. Gov't
Research Support; U.S. Gov't; P.H.S.

Publikations- och innehållstyp

vet (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy